<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30994182</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1898-018X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>3</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Cardiology journal</Title><ISOAbbreviation>Cardiol J</ISOAbbreviation></Journal><ArticleTitle>MiR-1/133 attenuates cardiomyocyte apoptosis and electrical remodeling in mice with viral myocarditis.</ArticleTitle><Pagination><StartPage>285</StartPage><EndPage>294</EndPage><MedlinePgn>285-294</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5603/CJ.a2019.0036</ELocationID><Abstract><AbstractText Label="BACKGROUND">The role of miR-1 and miR-133 in regulating the expression of potassium and calcium ion channels, and mediating cardiomyocyte apoptosis in mice with viral myocarditis (VMC) is investigated herein.</AbstractText><AbstractText Label="METHODS">Male Balb/c mice were randomly divided into groups: control group, VMC group, VMC + miR-1/133 mimics group, or VMC + miR-1/133 negative control (NC) group. VMC was induced with coxsackievirus B3 (CVB3). MiR-1/133 mimics ameliorated cardiac dysfunction in VMC mice and was compared to the VMC+NC group.</AbstractText><AbstractText Label="RESULTS">Hematoxylin and eosin staining showed a well-arranged myocardium without inflammatory cell infiltration in the myocardial matrix of the control group. However, in the VMC and VMC+NC groups, the myocardium was disorganized and swollen with necrosis, and the myocardial matrix was infiltrated with inflammatory cells. These changes were alleviated by miR-1/133 mimics. TUNEL staining revealed decreased cardiomyocyte apoptosis in the VMC + miR-1/133 mimics group compared with the VMC group. In addition, miR-1/133 mimics up-regulated the expression of miR-1 and miR-133, the potassium channel genes Kcnd2 and Kcnj2, as well as Bcl-2, and down-regulated the expression of the potassium channel suppressor gene Irx5, L-type calcium channel subunit gene a1c (Cacna1c), Bax, and caspase-9 in the myocardium of VMC mice. MiR-1/133 also up-regulated the protein levels of Kv4.2 and Kir2.1, and down-regulated the expression of CaV1.2 in the myocardium of VMC mice.</AbstractText><AbstractText Label="CONCLUSIONS">MiR-1 and miR-133 decreased cardiomyocyte apoptosis by mediating the expression of apoptosis-related genes in the hearts of VMC mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Institute, School of Control Science and Engineering, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mengmeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Cuifen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China. zhaocuifen@sdu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biomedical Engineering Institute, School of Control Science and Engineering, Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Qingyu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Zhifeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Research Room of Hypothermia Medicine, Qilu Hospital of Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Cardiol J</MedlineTA><NlmUniqueID>101392712</NlmUniqueID><ISSNLinking>1898-018X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C514350">CACNA1C protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020746">Calcium Channels, L-Type</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007473">Ion Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497019">Kcnd2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489461">Kir2.1 channel</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C517731">Mirn1 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C517732">Mirn133 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024661">Potassium Channels, Inwardly Rectifying</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051672">Shal Potassium Channels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051017" MajorTopicYN="N">Apoptosis Regulatory Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020746" MajorTopicYN="N">Calcium Channels, L-Type</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007473" MajorTopicYN="N">Ion Channels</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008564" MajorTopicYN="N">Membrane Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024661" MajorTopicYN="N">Potassium Channels, Inwardly Rectifying</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051672" MajorTopicYN="N">Shal Potassium Channels</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaphylaxis</Keyword><Keyword MajorTopicYN="N">cell apoptosis infarction</Keyword><Keyword MajorTopicYN="N">coronary</Keyword><Keyword MajorTopicYN="N">ion channels</Keyword><Keyword MajorTopicYN="N">miR-1</Keyword><Keyword MajorTopicYN="N">miR-133</Keyword><Keyword MajorTopicYN="N">psoriasis</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList><CoiStatement><b>Conflict of ineterest:</b> None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30994182</ArticleId><ArticleId IdType="pmc">PMC8015992</ArticleId><ArticleId IdType="doi">10.5603/CJ.a2019.0036</ArticleId><ArticleId IdType="pii">VM/OJS/J/58067</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002;12(9):735&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005;436(7048):214&#x2013;220. doi: 10.1038/nature03817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03817</ArticleId><ArticleId IdType="pubmed">15951802</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med. 2007;13(4):486&#x2013;491. doi: 10.1038/nm1569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1569</ArticleId><ArticleId IdType="pubmed">17401374</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YD, Hong YF, Yusufuaji Y, et al. Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation. Mol Med Rep. 2015;12(3):3243&#x2013;3248. doi: 10.3892/mmr.2015.3831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2015.3831</ArticleId><ArticleId IdType="pmc">PMC4526032</ArticleId><ArticleId IdType="pubmed">26005035</ArticleId></ArticleIdList></Reference><Reference><Citation>Girmatsion Z, Biliczki P, Bonauer A, et al. Changes in micro-RNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm. 2009;6(12):1802&#x2013;1809. doi: 10.1016/j.hrthm.2009.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2009.08.035</ArticleId><ArticleId IdType="pubmed">19959133</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa Martins PA, Bourajjaj M, Gladka M, et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation. 2008;118(15):1567&#x2013;1576. doi: 10.1161/CIRCULATIONAHA.108.769984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.769984</ArticleId><ArticleId IdType="pubmed">18809798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Xiao J, Lin H, et al. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res. 2009;37(3):e24. doi: 10.1093/nar/gkn1053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn1053</ArticleId><ArticleId IdType="pmc">PMC2647303</ArticleId><ArticleId IdType="pubmed">19136465</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman A, McNamara D. Myocarditis N Engl J Med. 2000;343(19):1388&#x2013;1398. doi: 10.1056/nejm200011093431908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm200011093431908</ArticleId><ArticleId IdType="pubmed">11070105</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Liu G, Liu Q, et al. RNA interference of influenza A virus replication by microRNA-adapted lentiviral loop short hairpin RNA. J Gen Virol. 2015;96(10):2971&#x2013;2981. doi: 10.1099/jgv.0.000247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000247</ArticleId><ArticleId IdType="pubmed">26296570</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers R, Timofeyev V, Li N, et al. Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling. Circ Arrhythm Electrophysiol. 2015;8(4):942&#x2013;950. doi: 10.1161/CIRCEP.114.002162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.114.002162</ArticleId><ArticleId IdType="pmc">PMC4545299</ArticleId><ArticleId IdType="pubmed">25995211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinali M, Arechavala-Gomeza V, Cirak S, et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology. 2011;76(4):346&#x2013;353. doi: 10.1212/WNL.0b013e318208811f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318208811f</ArticleId><ArticleId IdType="pmc">PMC3034418</ArticleId><ArticleId IdType="pubmed">21263136</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Carthy CM, Cheung P, et al. Structural and functional analysis of the 5&#x2032; untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. Virology. 1999;265(2):206&#x2013;217. doi: 10.1006/viro.1999.0048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.0048</ArticleId><ArticleId IdType="pubmed">10600593</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LM, Cai WB, Ye Q, et al. Comparison of plasma microRNA-1 and cardiac troponin T in early diagnosis of patients with acute myocardial infarction. World J Emerg Med. 2014;5(3):182&#x2013;186. doi: 10.5847/wjem.j.1920-8642.2014.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.5847/wjem.j.1920-8642.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4163815</ArticleId><ArticleId IdType="pubmed">25225581</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Ji R, Yue J, et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol. 2007;170(6):1831&#x2013;1840. doi: 10.2353/ajpath.2007.061170.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.061170</ArticleId><ArticleId IdType="pmc">PMC1899438</ArticleId><ArticleId IdType="pubmed">17525252</ArticleId></ArticleIdList></Reference><Reference><Citation>Busk PK, Cirera S. MicroRNA profiling in early hypertrophic growth of the left ventricle in rats. Biochem Biophys Res Commun. 2010;396(4):989&#x2013;993. doi: 10.1016/j.bbrc.2010.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2010.05.039</ArticleId><ArticleId IdType="pubmed">20470752</ArticleId></ArticleIdList></Reference><Reference><Citation>Car&#xe8; A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13(5):613&#x2013;618. doi: 10.1038/nm1582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1582</ArticleId><ArticleId IdType="pubmed">17468766</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Yu, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007;8:166. doi: 10.1186/1471-2164-8-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-8-166</ArticleId><ArticleId IdType="pmc">PMC1904203</ArticleId><ArticleId IdType="pubmed">17565689</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, Zhang H, Xiao J, et al. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem. 2010;25(6):571&#x2013;586. doi: 10.1159/000315076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000315076</ArticleId><ArticleId IdType="pubmed">20511702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CC, Chang YM, Pan CT, et al. Functional evolution of cardiac microRNAs in heart development and functions. Mol Biol Evol. 2014;31(10):2722&#x2013;2734. doi: 10.1093/molbev/msu217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu217</ArticleId><ArticleId IdType="pubmed">25063441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed D, Hong C, Chen IY, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res. 2007;100(3):416&#x2013;424. doi: 10.1161/01.RES.0000257913.42552.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000257913.42552.23</ArticleId><ArticleId IdType="pubmed">17234972</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz GP, Lino CA, Guedes EC, et al. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via type 1 angiotensin II receptor. Basic Res Cardiol. 2015;110(5):49. doi: 10.1007/s00395-015-0504-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-015-0504-7</ArticleId><ArticleId IdType="pubmed">26202011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedley PL, Carlsen AL, Christiansen KM, et al. MicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome. Scand J Clin Lab Invest. 2014;74(6):485&#x2013;491. doi: 10.3109/00365513.2014.905696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365513.2014.905696</ArticleId><ArticleId IdType="pmc">PMC4196592</ArticleId><ArticleId IdType="pubmed">24809446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31(6):659&#x2013;666. doi: 10.1093/eurheartj/ehq013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq013</ArticleId><ArticleId IdType="pubmed">20159880</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff JF. Viral myocarditis. A review. Am J Pathol. 1980;101(2):425&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1903609</ArticleId><ArticleId IdType="pubmed">6254364</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes MP, Lerner AM. Coxsackievirus myocarditis &#x2014; with special reference to acute and chronic effects. Prog Cardiovasc Dis. 1985;27(6):373&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">2988014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto C, Misaki T, Crumpacker CS, et al. Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral blood. Circulation. 1988;77(3):645&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">2830046</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci. 2007;120(Pt 17):3045&#x2013;3052. doi: 10.1242/jcs.010728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.010728</ArticleId><ArticleId IdType="pubmed">17715156</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Dong Y, Zhu N, et al. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer. 2014;13:124. doi: 10.1186/1476-4598-13-124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-13-124</ArticleId><ArticleId IdType="pmc">PMC4065091</ArticleId><ArticleId IdType="pubmed">24885920</ArticleId></ArticleIdList></Reference><Reference><Citation>Besser J, Malan D, Wystub K, et al. MiRNA-1/133a clusters regulate adrenergic control of cardiac repolarization. PLoS One. 2014;9(11):e113449. doi: 10.1371/journal.pone.0113449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113449</ArticleId><ArticleId IdType="pmc">PMC4240597</ArticleId><ArticleId IdType="pubmed">25415383</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini DL, Arruda EP, Agarwal P, et al. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell. 2005;123(2):347&#x2013;358. doi: 10.1016/j.cell.2005.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.004</ArticleId><ArticleId IdType="pmc">PMC1480411</ArticleId><ArticleId IdType="pubmed">16239150</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez R, Caballero R, Barana A, et al. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents. Cardiovasc Res. 2014;104(2):337&#x2013;346. doi: 10.1093/cvr/cvu203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvu203</ArticleId><ArticleId IdType="pubmed">25205296</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Lu, Yuan Ye, Li J, et al. MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the anti-oxidant network. Cell Stress Chaperones. 2015;20(3):411&#x2013;420. doi: 10.1007/s12192-014-0565-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-014-0565-9</ArticleId><ArticleId IdType="pmc">PMC4406930</ArticleId><ArticleId IdType="pubmed">25583113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Zhang Y, Shan H, et al. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc Res. 2009;84(3):434&#x2013;441. doi: 10.1093/cvr/cvp232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvp232</ArticleId><ArticleId IdType="pubmed">19581315</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz RJ, Zobel C, Cho HC, et al. Selective inhibition of inward rectifier K+ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes. Circ Res. 2004;95(3):325&#x2013;332. doi: 10.1161/01.RES.0000137727.34938.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000137727.34938.35</ArticleId><ArticleId IdType="pubmed">15231687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Ransom JF, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007;129(2):303&#x2013;317. doi: 10.1016/j.cell.2007.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.03.030</ArticleId><ArticleId IdType="pubmed">17397913</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>